US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability

US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium:
Harnessing the EHR: From Incentives to Sustainability

THE WOODLANDS, Texas, Oct. 5 /PRNewswire/ -- US Oncology, Inc. plans to
exhibit its oncology-specific electronic health record (EHR) system, iKnowMed,
at the American Society of Clinical Oncology's (ASCO) 2009 EHR Symposium:
Harnessing the EHR: From Incentives to Sustainability, October 6-7 in San
Francisco.

Developed by oncologists, iKnowMed(TM) addresses the unique needs of
community-based medical oncologists. The system serves as a decision support
tool to improve patient safety through clear, automated ordering of treatments
and automatic safety triggers. It increases charge capture accuracy and, in a
recent study conducted by US Oncology, was shown to improve gross charge
capture ranging from $35,000 to $86,000 per physician annually. iKnowMed can
also play a key role in driving patient accruals for clinical trials by
screening patients for eligibility requirements at the point of care, and, in
conjunction with Innovent Oncology, supports pay-for-performance initiatives
with reports that provide evidence of treatment patterns and case data to
support treatment decisions.

iKnowMed is a Web-based application that can be securely accessed any time of
day, from any computer with internet access. The iKnowMed team includes
physicians, nurse specialists and doctors of pharmacy. Their combined
knowledge of the complexities of cancer care keeps the system current,
relevant and user friendly.

Symposium attendees will have an opportunity to participate in educational
sessions addressing the American Recovery and Reinvestment Act's impact on
oncology, EHRs as a quality tool, implementation project management, policy
and procedures, and the return on investment an EHR can offer an oncology
practice. To learn more about the symposium, visit www.asco.org/ehrsymposium.

"EHRs can significantly improve patient care," says Cindy Chavez, vice
president of iKnowMed at US Oncology. "ASCO has identified EHRs as an
important vehicle for advancing quality care. We are thrilled by the
opportunity to exhibit at the 2009 EHR Symposium and communicate first-hand
what the iKnowMed system offers to the oncology community."

About US Oncology
US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with
physicians, payers, biotechnology, pharmaceutical and medical equipment
manufacturers, to identify and deliver innovative services that enhance
patient access to advanced cancer care. US Oncology supports one of the
nation's foremost cancer treatment and research networks, accelerating the
availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care
delivery system--from drug development to distribution and outcomes
measurement--enabling the company to help increase the efficiency and safety
of cancer care. According to the company's last quarterly earnings report, US
Oncology is affiliated with 1,236 physicians operating in 476 locations,
including 94 radiation oncology facilities in 39 states. For more information,
visit the company's Web site, www.usoncology.com.

About ASCO
The American Society of Clinical Oncology (ASCO) is the world's leading
professional organization representing physicians who care for people with
cancer. With more than 27,000 members, ASCO is committed to improving cancer
care through scientific meetings, educational programs and peer-reviewed
journals. For ASCO information and resources, visit www.asco.org.
Patient-oriented cancer information is available at www.cancer.net.

SOURCE US Oncology, Inc.

Jennifer Horspool of US Oncology, Inc., +1-281-863-6739,
Jennifer.Horspool@usoncology.com